Abstract
The last couple of decades has witnessed that an amalgamation of multidisciplinary branches of science come together in the form of ‘Bioinformatics’ and made a substantial impact on the drug designing process. The applicability of Bioinformatics approaches has been able to lower down the overall cost and time of drug discovery and development. The Computer Aided Drug Designing System (CADDS) using extensive applicability of Bioinformatics has been recognized as one step ahead to carry out the primary high throughput virtual screening as an economically viable solution to the problem. The present article discusses the applicability of various Bioinformatics tools for virtual screening and molecular dynamics of selected molecules/ active ingredients derived from herbs, semi-synthetic and synthetic compounds, to predict their possible therapeutic interventions in diabetes induced neuropathy and neurodegenerative disorders. The article ends by summarizing the application of the virtual screening, lead optimization and predictions of bioavailability and bioactivity in the experimental drug development research.
Keywords: Drug discovery, CADD, Homology modeling, molecular interaction, simulations, neurological disorders.
Current Topics in Medicinal Chemistry
Title:Critical Role of Computer Simulations in Drug Discovery and Development
Volume: 17 Issue: 21
Author(s): Prachi Srivastava*Anshul Tiwari
Affiliation:
- AMITY Institute of Biotechnology, AMITY University Uttar Pradesh Lucknow, Lucknow, UP,India
Keywords: Drug discovery, CADD, Homology modeling, molecular interaction, simulations, neurological disorders.
Abstract: The last couple of decades has witnessed that an amalgamation of multidisciplinary branches of science come together in the form of ‘Bioinformatics’ and made a substantial impact on the drug designing process. The applicability of Bioinformatics approaches has been able to lower down the overall cost and time of drug discovery and development. The Computer Aided Drug Designing System (CADDS) using extensive applicability of Bioinformatics has been recognized as one step ahead to carry out the primary high throughput virtual screening as an economically viable solution to the problem. The present article discusses the applicability of various Bioinformatics tools for virtual screening and molecular dynamics of selected molecules/ active ingredients derived from herbs, semi-synthetic and synthetic compounds, to predict their possible therapeutic interventions in diabetes induced neuropathy and neurodegenerative disorders. The article ends by summarizing the application of the virtual screening, lead optimization and predictions of bioavailability and bioactivity in the experimental drug development research.
Export Options
About this article
Cite this article as:
Srivastava Prachi*, Tiwari Anshul, Critical Role of Computer Simulations in Drug Discovery and Development, Current Topics in Medicinal Chemistry 2017; 17 (21) . https://dx.doi.org/10.2174/1568026617666170403113541
DOI https://dx.doi.org/10.2174/1568026617666170403113541 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Chronic Kidney Disease
The scope of the special thematic issue includes but not limited to the mechanism of chronic kidney disease (CKD), the treatment of renal fibrosis and early diagnosis of CKD and so on. We also welcome manuscripts from other scientific research area with respect to internal medicine. Cell death has been ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ubiquitin-Protein Ligases - Novel Therapeutic Targets?
Current Protein & Peptide Science Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design One-year Outcome of Shanghai Mild Cognitive Impairment Cohort Study
Current Alzheimer Research Insights Into Effects of Ellagic Acid on the Nervous System: A Mini Review
Current Pharmaceutical Design Heme Oxygenase-1 Dysregulation in the Brain: Implications for HIVAssociated Neurocognitive Disorders
Current HIV Research Editorial [ Proteases and Phospholipases in CNS Disorders Guest Editor: Swapan K. Ray ]
CNS & Neurological Disorders - Drug Targets A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Current Drug Targets HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy
Current Neurovascular Research The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age
Current Neuropharmacology Inhibitory Mechanism of An Anticancer Drug, Bexarotene Against Amyloid β Peptide Aggregation: Repurposing Via Neuroinformatics Approach
Current Pharmaceutical Design Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimers Disease, Depression, and Parkinsons Disease
Current Bioactive Compounds Probenecid: An Emerging Tool for Neuroprotection
CNS & Neurological Disorders - Drug Targets Nitric Oxide, Epileptic Seizures, and Action of Antiepileptic Drugs
CNS & Neurological Disorders - Drug Targets Editorial Regulating Gene Expression at the Post-Transcriptional Level: Spotlight on RNA-Binding Proteins [Hot Topic: Proteins Involved in Post-Transcriptional Control of Gene Expression]
Current Protein & Peptide Science Pharmacological Strategies that Affect HIF-1 in the Ischemic Brain: Focus on Hydroxylases Activity and Protein Kinase Pathways
Current Signal Transduction Therapy Elicitation of Dopaminergic Features of Parkinson’s Disease in C. elegans by Monocrotophos, an Organophosphorous Insecticide
CNS & Neurological Disorders - Drug Targets Kainate Receptors and Pain: From Dorsal Root Ganglion to the Anterior Cingulate Cortex
Current Pharmaceutical Design Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior
Current Genomics PCR/SSCP Detects Reliably and Efficiently DNA Sequence Variations in Large Scale Screening Projects
Combinatorial Chemistry & High Throughput Screening